ZIRCON Trial: Promising results for [89Zr]Zr-girentuximab PET-CT in detecting clear-cell renal cell carcinoma! Brian Shuch, MD 🔶 Sensitivity: 85.5% 🔶 Specificity: 87% 🔶 No safety signals observed. Could this be a game changer in RCC diagnosis? #RCC #PETCT #Oncology
Joined a PET-CT service as a Rad or Tech within the last two years? Our Essentials of PET-CT: Scenarios and Solutions course is designed just for you. Find out more about the course 👉 bit.ly/ScenariosandSo… #NHS #Petct #RadiologyTech #RadTech #nhsstaff Alliance Medical Ltd